Back

State of the Art in antidiabetic treatment to prevent CVD

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: The right glucose-lowering drugs for the right patient Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Anna Norhammar

Karolinska Institute, Stockholm (Sweden)

3 More presentations in this session

Presentation thumbnail
Albuminuria as a predictor of incident ischemic stroke and myocardial infarction in patients with type 2 diabetes but without cardiovascular disease: A Danish cohort study
Mrs M. Fangel (Aalborg, DK)
Abstract Slides Video
Presentation thumbnail
Cardiovascular risk profiles and outcomes in patients with type 2 diabetes - Implications for choice of new diabetes therapies
Mrs M. Elmegaard (Copenhagen, DK)
Abstract Slides Video
Presentation thumbnail
Heart failure risk stratification and efficacy of dapagliflozin in patients with type 2 diabetes mellitus
Doctor D. Berg (Boston, US)
Abstract Slides Video

Access the full session

Session thumbnail
The right glucose-lowering drugs for the right patient

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Case 1 - a middle-aged male with T2DM: polypharmacy in a primary prevention setting
thumbnail
Congress Presentation
Cardiovascular risk reduction: should we target pre-diabetes?
thumbnail
Webinar
Prevention of heart failure in diabetic patients at population level

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources